about
Genetic immunization with CDR3-based fusion vaccine confers protection and long-term tumor-free survival in a mouse model of lymphomaEfficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation.The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: emerging gene-based therapeutic approaches.DNA vaccination strategies for anti-tumour effective gene therapy protocols.Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.In vitro end points for the assessment of cellular immune response-modulating drugs.A human neuroblastoma xenograft model for 125-I-metaiodobenzylguanidine biodistribution studies.Asthma, allergy and the Olympics: a 12-year survey in elite athletes.Increased nerve growth factor serum levels in top athletes.Enhancement of plasmid-mediated transgene expression.Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization.Strategies for improving DNA vaccine performance.ApoE gene delivery inhibits severe hypercholesterolemia in newborn ApoE-KO mice.Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety.Human decay accelerating factor transgenic pigs for xenotransplantation obtained by sperm-mediated gene transferSperm-mediated gene transfer: Production of pigs transgenic for a human regulator of complement activationAnti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma modelA blueprint for DNA vaccine designCombination of cord blood-derived human hepatic progenitors and hepatogenic factors strongly improves recovery after acute liver injury in mice through modulation of the Wnt/β-catenin signaling
P50
Q33814247-981D10E9-06C4-449A-89D8-9FC1D93AB843Q34392894-1389FE6F-3956-41EC-8472-E42DA0985A2BQ37698031-77E72BF9-0CF2-43D0-939A-E04B9CE47D83Q37730620-B91F1C5B-385C-4C5B-B61F-9770F9817876Q37899985-2C58197B-60E2-4E48-965D-4FD486ACEF56Q38088820-6D220D60-161E-4122-B629-8EB985445BC8Q41141063-0EF14DF2-8172-46A3-9A9F-55B2C5186AECQ41242653-FF1A3476-0251-4E70-9306-60F46244EAC0Q45856400-53492528-D138-49F3-AB59-A3E504DD4D89Q45863973-4AE72409-65B2-4B99-BC3B-38F2750CD90BQ45873428-FBDC6F8B-C51C-40C4-8776-0DD492EF5666Q50853844-9D9D3B8A-7024-444F-B248-1F3EDB13FB5CQ51979757-3DFFDDEA-2500-44DE-A3D0-3027BE185353Q51988941-7645DA33-2C17-44BF-A46B-DD99F9039A6AQ59505138-3A3DF882-D91C-4DCE-825B-6B4DD6ED7268Q59505141-DFE4CB58-88DB-4CD7-A304-C1D05B36B12EQ80949000-511DB575-C9EE-46DE-8535-AA116DF4BB2AQ87642202-DD74BEE7-2E54-4F26-8576-51D4C7A0EFDAQ92815753-2AA6580C-1462-4A78-BBA5-B74CA43BD445
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Daniela Fioretti
@ast
Daniela Fioretti
@en
Daniela Fioretti
@es
Daniela Fioretti
@nl
type
label
Daniela Fioretti
@ast
Daniela Fioretti
@en
Daniela Fioretti
@es
Daniela Fioretti
@nl
prefLabel
Daniela Fioretti
@ast
Daniela Fioretti
@en
Daniela Fioretti
@es
Daniela Fioretti
@nl
P106
P21
P31
P496
0000-0003-2879-4028